Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neurofibromatosis 1 1Melanoma 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Cisplatin 2selinexor 1cabozantinib 1atezolizumab 1X-Rays 1Quality of Life 1Pemetrexed 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy 1Imatinib Mesylate 1Hydroxyurea 1Etoposide 1Endoscopic Mucosal Resection 1Drug Therapy 1Cytoreduction Surgical Procedures 1Carboplatin 1Biological Therapy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × Acetaminophen × CNS × Clear all
NCT01607905 2023-01-26

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

Karyopharm Therapeutics Inc

Phase 1 Completed
192 enrolled 29 charts
CNSDermatologicGastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Glioblastoma, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡